{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T15:18:38Z","timestamp":1783437518392,"version":"3.54.6"},"reference-count":38,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Opioid prescribing has decreased in the US for more than a decade. However, less is known about how prescribing trends differ by prescriber specialty and separately for short-term and long-term opioid prescribing for which the indications, clinical decision-making, and potential for harm vary substantially.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To characterize opioid analgesic prescribing trends in the US between January 1, 2010, and December 31, 2024, by prescriber specialty, analyzing short-term and long-term opioid use episodes separately.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This cross-sectional study used administrative claims data for commercially insured and Medicare Advantage patients (aged \u226565 years and &amp;lt;65 years with long-term disability) with at least 90 days of enrollment in medical and prescription coverage. Statistical analysis was performed from May 2025 to September 2025.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n Prescribing volume, daily dose, and prescription duration.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n The study identified 110\u202f288\u202f218 opioid fills by 14\u202f959\u202f612 patients during the 15-year study period. Among opioid fills, 59.4% were attributed to female patients; the median (IQR) age at opioid fill was 61 (50-71) years. From 2010 to 2024, decreases in opioid prescribing were greater for long-term than short-term opioid use episodes (eg, commercial cohort: 81.3% reduction [from 33.2 fills per 100-person years in 2010 to 6.2 in 2024] and 74.6% reduction [from 36.2 fills per 100-person years in 2010 to 9.2 in 2024]), respectively. The proportion of all opioid fills written by primary care clinicians decreased (eg, Medicare Advantage with disability cohort: from 52.2% to 47.2%), whereas those written by pain medicine specialists increased (eg, Medicare Advantage with disability cohort: from 17.1% to 25.7%). Distinct trends for short-term and long-term opioid use episodes were observed in prescription characteristics, such as daily dose and duration.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this cross-sectional study of opioid prescribing trends in the US between 2010 and 2024, decreases in prescribing were greatest in long-term opioid use episodes, and prescribing was increasingly concentrated among pain medicine specialists. These findings suggest the need to balance reductions in opioid prescribing with provision of nonopioid pain treatments and raise concerns about access to care for patients taking opioids for chronic pain management.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.22016","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T15:11:37Z","timestamp":1783437097000},"page":"e2622016","source":"Crossref","is-referenced-by-count":0,"title":["Short-Term and Long-Term Opioid Prescribing by Specialty, 2010 to 2024"],"prefix":"10.1001","volume":"9","author":[{"given":"Michele J.","family":"Buonora","sequence":"first","affiliation":[{"name":"Division of General Internal Medicine, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebekah","family":"Heckmann","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Yale School of Medicine, New Haven, Connecticut"},{"name":"Department of Anesthesiology, University of Michigan Medical School, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna L.","family":"Starrels","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitra","family":"Ahadpour","sequence":"additional","affiliation":[{"name":"Center for Drug Evaluation and Research, Office of Translational Sciences, US Food and Drug Administration, Silver Spring, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara A.","family":"Hevesi","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph S.","family":"Ross","sequence":"additional","affiliation":[{"name":"Section of General Medicine and National Clinician Scholars Program, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut"},{"name":"Department of Health Policy and Management, Yale School of Public Health, New Haven, Connecticut"},{"name":"Center for Outcomes Research and Evaluation, Yale-New Haven Health, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly M.","family":"Jeffery","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Mayo Clinic, Rochester, Minnesota"},{"name":"Division of Health Care Delivery Research, Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"issue":"6","key":"zoi260613r1","doi-asserted-by":"publisher","first-page":"367","DOI":"10.7326\/M18-1243","article-title":"Opioid prescribing in the United States before and after the Centers for Disease Control and Prevention\u2019s 2016 opioid guideline.","volume":"169","author":"Bohnert","year":"2018","journal-title":"Ann Intern Med"},{"issue":"9","key":"zoi260613r2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.32507","article-title":"State-to-state variation in opioid dispensing changes following the release of the 2016 CDC Guideline for Prescribing Opioids for Chronic Pain.","volume":"6","author":"Lyu","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"3","key":"zoi260613r3","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.0665","article-title":"Trends and patterns of geographic variation in opioid prescribing practices by state, United States, 2006-2017.","volume":"2","author":"Schieber","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"4","key":"zoi260613r4","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1001\/jamainternmed.2018.6989","article-title":"County-level opioid prescribing in the United States, 2015 and 2017.","volume":"179","author":"Guy","year":"2019","journal-title":"JAMA Intern Med"},{"key":"zoi260613r5","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2023.109933","article-title":"Change in opioid and buprenorphine prescribers and prescriptions by specialty, 2016-2021.","volume":"248","author":"Larochelle","year":"2023","journal-title":"Drug Alcohol Depend"},{"issue":"9","key":"zoi260613r6","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/j.jval.2021.04.1274","article-title":"Opioid prescribing in United States health systems, 2015 to 2019.","volume":"24","author":"Khouja","year":"2021","journal-title":"Value Health"},{"issue":"7","key":"zoi260613r7","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.16860","article-title":"Changes in initial opioid prescribing practices after the 2016 release of the CDC guideline for prescribing opioids for chronic pain.","volume":"4","author":"Goldstick","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"10","key":"zoi260613r8","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.18553\/jmcp.2021.27.10.1352","article-title":"Association of 3 CDC opioid prescription guidelines for chronic pain and 2 payer pharmacy coverage changes on opioid initiation practices.","volume":"27","author":"Togun","year":"2021","journal-title":"J Manag Care Spec Pharm"},{"issue":"6","key":"zoi260613r9","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.11826","article-title":"Association of the 2016 US Centers for Disease Control and Prevention opioid prescribing guideline with changes in opioid dispensing after surgery.","volume":"4","author":"Sutherland","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"1","key":"zoi260613r10","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2023.4731","article-title":"Opioid prescribing patterns after imposition of setting-specific limits on prescription duration.","volume":"5","author":"Allen","year":"2024","journal-title":"JAMA Health Forum"},{"issue":"7","key":"zoi260613r11","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1093\/pm\/pnaa470","article-title":"Longitudinal dose trajectory among patients tapering long-term opioids.","volume":"22","author":"Fenton","year":"2021","journal-title":"Pain Med"},{"issue":"16","key":"zoi260613r12","doi-asserted-by":"publisher","first-page":"4088","DOI":"10.1007\/s11606-022-07551-z","article-title":"Cycles of chronic opioid therapy following mandatory prescription drug monitoring program legislation: a retrospective cohort study.","volume":"37","author":"Allen","year":"2022","journal-title":"J Gen Intern Med"},{"issue":"7","key":"zoi260613r14","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1111\/add.15359","article-title":"Laws limiting prescribing and dispensing of opioids in the United States, 1989-2019.","volume":"116","author":"Davis","year":"2021","journal-title":"Addiction"},{"key":"zoi260613r15","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2022.103888","article-title":"U.S. state policies on opioid prescribing during the peak of the prescription opioid crisis: associations with opioid overdose mortality.","volume":"110","author":"Buonora","year":"2022","journal-title":"Int J Drug Policy"},{"key":"zoi260613r16","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-023-08528-2","article-title":"Paths forward for clinicians amidst the rise of unregulated clinical decision support software: our perspective on NarxCare.","author":"Buonora","journal-title":"J Gen Intern Med"},{"issue":"2","key":"zoi260613r17","doi-asserted-by":"publisher","first-page":"139","DOI":"10.18060\/3911.0046","article-title":"Deploying prescription drug monitoring to address the overdose crisis: ideology meets reality.","volume":"15","year":"2018","journal-title":"Indiana Health Law Rev"},{"issue":"1","key":"zoi260613r18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6501e1","article-title":"CDC Guideline for Prescribing Opioids for Chronic Pain - United States, 2016.","volume":"65","author":"Dowell","year":"2016","journal-title":"MMWR Recomm Rep"},{"issue":"11","key":"zoi260613r22","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1093\/pm\/pnac068","article-title":"Changes in opioid dispensing by medical specialties after the release of the 2016 CDC Guideline for Prescribing Opioids for Chronic Pain.","volume":"23","author":"Salvatore","year":"2022","journal-title":"Pain Med"},{"issue":"5","key":"zoi260613r23","doi-asserted-by":"publisher","first-page":"e153","DOI":"10.1016\/j.amepre.2018.06.008","article-title":"Opioid prescribing by specialty and volume in the U.S.","volume":"55","author":"Guy","year":"2018","journal-title":"Am J Prev Med"},{"issue":"7","key":"zoi260613r24","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1093\/pm\/pnz344","article-title":"Opioid prescribing to Medicare Part D Enrollees, 2013-2017: shifting responsibility to pain management providers.","volume":"21","author":"Romman","year":"2020","journal-title":"Pain Med"},{"issue":"12","key":"zoi260613r25","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.46426","article-title":"Opioid prescribing by US Surgeons, 2016-2022.","volume":"6","author":"Zhang","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"3","key":"zoi260613r26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7103a1","article-title":"CDC Clinical Practice Guideline for Prescribing Opioids for Pain - United States, 2022.","volume":"71","author":"Dowell","year":"2022","journal-title":"MMWR Recomm Rep"},{"issue":"4","key":"zoi260613r27","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1093\/pm\/pny307","article-title":"Challenges with implementing the Centers for Disease Control and Prevention opioid guideline: a consensus panel report.","volume":"20","author":"Kroenke","year":"2019","journal-title":"Pain Med"},{"issue":"9","key":"zoi260613r28","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1001\/jama.2018.0899","article-title":"Effect of opioid vs nonopioid medications on pain-related function in patients with chronic back pain or hip or knee osteoarthritis pain: the SPACE randomized clinical trial.","volume":"319","author":"Krebs","year":"2018","journal-title":"JAMA"},{"issue":"10180","key":"zoi260613r30","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1016\/S0140-6736(19)30428-3","article-title":"Inappropriate opioid prescription after surgery.","volume":"393","author":"Neuman","year":"2019","journal-title":"Lancet"},{"issue":"12","key":"zoi260613r31","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1016\/j.mayocp.2017.10.010","article-title":"A conceptual framework for understanding unintended prolonged opioid use.","volume":"92","author":"Hooten","year":"2017","journal-title":"Mayo Clin Proc"},{"issue":"10","key":"zoi260613r32","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1176\/appi.ajp.21070721","article-title":"Diagnosing prescription opioid use disorder in patients using prescribed opioids for chronic pain.","volume":"179","author":"Hasin","year":"2022","journal-title":"Am J Psychiatry"},{"key":"zoi260613r34","doi-asserted-by":"publisher","first-page":"k2833","DOI":"10.1136\/bmj.k2833","article-title":"Trends in opioid use in commercially insured and Medicare Advantage populations in 2007-16: retrospective cohort study.","volume":"362","author":"Jeffery","year":"2018","journal-title":"BMJ (Clin Res Ed)"},{"issue":"7","key":"zoi260613r35","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1377\/hlthaff.2014.0038","article-title":"Optum Labs: building a novel node in the learning health care system.","volume":"33","author":"Wallace","year":"2014","journal-title":"Health Aff (Millwood)"},{"issue":"6","key":"zoi260613r36","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1097\/AJP.0b013e318169d03b","article-title":"De facto long-term opioid therapy for noncancer pain.","volume":"24","author":"Von Korff","year":"2008","journal-title":"Clin J Pain"},{"issue":"5","key":"zoi260613r38","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1111\/papr.12359","article-title":"Opioid prescribing laws and emergency department guidelines for chronic non-cancer pain in Washington State.","volume":"16","author":"Skaer","year":"2016","journal-title":"Pain Pract"},{"key":"zoi260613r33","author":"Chou"},{"key":"zoi260613r37","volume-title":"Stata\/SE: Release 17","author":"StataCorp","year":"2021"},{"key":"zoi260613r13","unstructured":"Substance Abuse and Mental Health Services Administration. Key Substance Use and Mental Health Indicators in the United States: Results From the 2023 National Survey on Drug Use and Health. Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration; 2024. HHS publication PEP24-07-021, NSDUH Series H-59. Accessed May 19, 2026. https:\/\/www.samhsa.gov\/data\/report\/2023-nsduh-annual-national-report."},{"key":"zoi260613r19","unstructured":"Michigan OPEN. Opioid prescribing. Accessed April 3, 2025. https:\/\/michigan-open.org\/prescribing-recommendations\/"},{"key":"zoi260613r20","unstructured":"Michigan Arthroplasty Registry Collaborative Quality Initiative (MARCQI). Pain-control pathway: evidence based opioid prescribing guidelines for elective primary total hip and knee arthroplasty in opioid naive patients. Accessed April 3, 2025. https:\/\/marcqi.org\/paincontrol\/"},{"key":"zoi260613r21","unstructured":"New York City Department of Health. New York City Emergency Department Discharge Opioid Prescribing Guidelines. Accessed April 3, 2025. https:\/\/www.nyc.gov\/site\/doh\/providers\/health-topics\/opioid-prescribing-resources-for-emergency-departments.page"},{"key":"zoi260613r29","unstructured":"Chou R, Wagner J, Ahmed AY, et al. Treatments for Acute Pain: A Systematic Review. Agency for Healthcare Research and Quality; 2020. Comparative Effectiveness Review No. 240. Accessed May 31, 2026. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK566506\/"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2851281\/buonora_2026_oi_260613_1782850668.04775.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T15:11:55Z","timestamp":1783437115000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2851281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.22016","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]}}}